MediPharm Labs Achieves Debt-Free Milestone
Company Announcements

MediPharm Labs Achieves Debt-Free Milestone

Story Highlights

MediPharm Labs (TSE:LABS) has released an update.

MediPharm Labs Corp., a pharmaceutical company specializing in cannabis-based health products, has announced the repayment of its entire convertible debt of $2.1 million, achieving a materially debt-free status. The company now boasts a strong financial standing with over $13 million in cash reserves and a near breakeven adjusted EBITDA, positioning it confidently for future growth and investment in its operations.

For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskMediPharm Labs to Announce Q3 2024 Results
Catie PowersMEDIF Upcoming Earnings Report: What to Expect?
TipRanks Canadian Auto-Generated NewsdeskMediPharm Labs Leadership Transition and Future Focus
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App